EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improving the Therapeutic Efficacy of Anti-Cancer Drugs through Nanotechnology

Dr. John Doe

American Journal of Pharmaceutics · 28.02.2022 · 3 (1) · 16-31

DOI: 10.71465/ajph2163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Pharmaceutics, online erschienen am 28.02.2022. Verfasst von Dr. John Doe. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanotechnology has emerged as a promising strategy to enhance the therapeutic efficacy of anti-cancer drugs. Traditional cancer treatments often face limitations such as poor bioavailability, toxicity, and resistance. Nanotechnology provides innovative solutions by utilizing nanoscale materials to improve the delivery, effectiveness, and targeting of anti-cancer drugs. This article explores the role of nanotechnology in improving drug bioavailability, targeting specific tumor sites, minimizing side effects, and overcoming resistance mechanisms. The application of nanocarriers, such as liposomes, dendrimers, and nanoparticles, offers new avenues in precision cancer therapy. Furthermore, it discusses the clinical challenges and future directions for integrating nanotechnology into cancer treatment.

Zitieren

APA

Doe, D. J. (2022). Improving the Therapeutic Efficacy of Anti-Cancer Drugs through Nanotechnology. American Journal of Pharmaceutics, 3(1), 16-31. https://doi.org/10.71465/ajph2163

Vancouver

Doe DJ. Improving the Therapeutic Efficacy of Anti-Cancer Drugs through Nanotechnology. American Journal of Pharmaceutics. 2022;3(1):16-31. doi:10.71465/ajph2163

BibTeX
@article{Doe2022,
  author = {Doe, Dr. John},
  title = {Improving the Therapeutic Efficacy of Anti-Cancer Drugs through Nanotechnology},
  journal = {American Journal of Pharmaceutics},
  year = {2022},
  volume = {3},
  number = {1},
  pages = {16--31},
  doi = {10.71465/ajph2163}
}
Kostenlos starten →